Skip to main content

BioPharma Credit

data as at: 28/05/2020
Company website
ObjectiveTo generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.
Management groupPharmakon Advisors
AIC sectorDebt - Direct Lending
Launch date27/03/2017
Financial year endDecember
DomicileUnited Kingdom

Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.

Dividends

Dividends displayed in traded currency.

Ex-Dividend DateDividend amountDividend typeSpecial dividendFinancial year
21/05/20200.018IncomeNo2020
27/02/20200.018IncomeNo2019
27/02/20200.013CapitalYes2019
14/11/20190.018IncomeNo2019
15/08/20190.018IncomeNo2019
View dividend history
Dividend cover (years)Revenue reserves (m)
0.4341.69

Trading information

ISINTIDMTraded currency
GB00BDGKMY29BPCRUSD

Traded volumes (number of shares)

Yesterday1 month1 year5 years
Total2,772,65412,933,745265,245,5960
AverageN/A714,4801,052,1700

Traded values (m)

Yesterday1 month1 year5 years
Total2.6612.38263.940.00
AverageN/A0.681.050.00

Data provided by Morningstar. Company documents provided by Financial Express. 

Company announcements

Company documents